CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9

Herpes simplex virus type 1 (HSV-1) is a leading cause of encephalitis and infectious blindness. The commonly used clinical therapeutic drugs are nucleoside analogues such as acyclovir. However, current drugs for HSV cannot eliminate the latent virus or viral reactivation. Therefore, the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Min, Wang, Huadong, Liu, Tongtan, Han, Zengpeng, Lin, Kunzhang, Shi, Qing, Zheng, Ning, Ye, Tao, Gong, Huinan, Xu, Fuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302303/
https://www.ncbi.nlm.nih.gov/pubmed/37375504
http://dx.doi.org/10.3390/pathogens12060814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302303/
https://www.ncbi.nlm.nih.gov/pubmed/37375504
http://dx.doi.org/10.3390/pathogens12060814

Ejemplares similares